P731.F - Medexus Pharmaceuticals Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20193/31/20183/31/20173/31/2016
Total Revenue33,864.02810,009.1676,207.1393,750.236
Cost of Revenue13,858.7144,967.5412,778.3931,295.999
Gross Profit20,005.3145,041.6263,428.7462,454.237
Operating Expenses
Research Development----
Selling General and Administrative20,849.7517,862.4376,803.6656,750.581
Non Recurring----
Others----
Total Operating Expenses34,772.89112,844.2729,606.0528,152.301
Operating Income or Loss-908.863-2,835.105-3,398.913-4,402.065
Income from Continuing Operations
Total Other Income/Expenses Net-5,391.35-647.541,567.0262,102.771
Earnings Before Interest and Taxes-908.863-2,835.105-3,398.913-4,402.065
Interest Expense-3,877.995-1,186.675-1,082.294-1,001.046
Income Before Tax-6,300.213-3,482.645-1,831.887-2,299.294
Income Tax Expense222.026---
Minority Interest----
Net Income From Continuing Ops-6,522.239-3,482.645-1,831.887-2,299.294
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,522.239-3,482.645-1,831.887-2,299.294
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,522.239-3,482.645-1,831.887-2,299.294